G A Vilos1. 1. Saint Joseph's Health Centre, University of Western Ontario, London, Canada. georgev@stj.stjosephs.london.on.ca
Abstract
OBJECTIVE: To determine the feasibility and clinical outcome of using a new hysteroscopic bipolar electrosurgical system. DESIGN: Pilot feasibility study. SETTING: A university teaching hospital. PATIENT(S): Eight women with intrauterine lesions. Six women with impaired fertility and two with abnormal bleeding were selected. INTERVENTION(S): Three septoplasties, two adhesiolysis procedures, two polypectomies, one myomectomy, and one endometrial ablation were performed with the Versapoint system (Gynecare Inc., Menlo Park, CA). MAIN OUTCOME MEASURE(S): Fertility, obstetric outcome, and menstrual blood loss. RESULT(S): Five of six patients conceived six normal fetuses. Menstrual blood loss improved significantly in the remaining two patients. CONCLUSION(S): The Versapoint system is an effective alternative in the treatment of intrauterine lesions.
OBJECTIVE: To determine the feasibility and clinical outcome of using a new hysteroscopic bipolar electrosurgical system. DESIGN: Pilot feasibility study. SETTING: A university teaching hospital. PATIENT(S): Eight women with intrauterine lesions. Six women with impaired fertility and two with abnormal bleeding were selected. INTERVENTION(S): Three septoplasties, two adhesiolysis procedures, two polypectomies, one myomectomy, and one endometrial ablation were performed with the Versapoint system (Gynecare Inc., Menlo Park, CA). MAIN OUTCOME MEASURE(S): Fertility, obstetric outcome, and menstrual blood loss. RESULT(S): Five of six patients conceived six normal fetuses. Menstrual blood loss improved significantly in the remaining two patients. CONCLUSION(S): The Versapoint system is an effective alternative in the treatment of intrauterine lesions.